BesaoT35 Friday, 05/01/20 11:24:20 AM Re: None Post # of 6164 After all the reverse splits and falling prices the market cap for NVIV is very low. It is below $10 million. If the neuro - spinal scaffold (NSS) is a success it has to be worth more than that I think. The first trial was a success. That makes me think the Inspire 2 could be successful. This is all before even using stem cells or growth factors. After all this time NVIV might have competitors whereas a few years ago there were no direct competitors. What do people think NVIV would be worth after approval for use of the NSS and then use of stem cells? I do know that management is corrupt and perhaps incompetent as well. I think our previous CEO Dr. Reynolds actually is in jail or soon to be sentenced to go to jail. That is real undeniable corruption. This is all a shame. I think about helping patients and how all the delay has hampered finding treatment.